Denali Therapeutics Inc. (DNLI)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 3.44B |
| Enterprise value | 2.55B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 11.47 |
| Price/book (mrq) | 2.36 |
| Enterprise value/revenue | 8.63 |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 1.39 |
| 52-week change 3 | -15.23% |
| S&P500 52-week change 3 | 18.96% |
| 52-week high 3 | 28.75 |
| 52-week low 3 | 14.56 |
| 50-day moving average 3 | 21.47 |
| 200-day moving average 3 | 19.54 |
Share statistics
| Avg vol (3-month) 3 | 1.19M |
| Avg vol (10-day) 3 | 1.09M |
| Shares outstanding 5 | 142.61M |
| Implied shares outstanding 6 | 142.61M |
| Float 8 | 123.16M |
| % held by insiders 1 | 13.72% |
| % held by institutions 1 | 84.24% |
| Shares short (15 Jul 2024) 4 | 7.09M |
| Short ratio (15 Jul 2024) 4 | 5.01 |
| Short % of float (15 Jul 2024) 4 | 5.82% |
| Short % of shares outstanding (15 Jul 2024) 4 | 4.97% |
| Shares short (prior month 14 Jun 2024) 4 | 8.86M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -46.46% |
| Operating margin (ttm) | -70.46% |
Management effectiveness
| Return on assets (ttm) | -8.70% |
| Return on equity (ttm) | -11.33% |
Income statement
| Revenue (ttm) | 295.39M |
| Revenue per share (ttm) | 2.10 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -207.2M |
| Net income avi to common (ttm) | -137.24M |
| Diluted EPS (ttm) | -0.94 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 936.87M |
| Total cash per share (mrq) | 6.57 |
| Total debt (mrq) | 50.55M |
| Total debt/equity (mrq) | 3.47% |
| Current ratio (mrq) | 11.79 |
| Book value per share (mrq) | 10.21 |
Cash flow statement
| Operating cash flow (ttm) | -412.81M |
| Levered free cash flow (ttm) | -343.06M |
© 2024 Yahoo. All rights reserved.